Mammaglobin as a potential molecular target for breast cancer drug delivery

doi:10.1186/1475-2867-9-8

Cancer Cell International

Volume 9

Viewing options:

Abstract
Full text
PDF (772KB)
Additional files

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on PubMed Central
Other articles by authors
on Google Scholar

Zuo L
Li L
Wang Q
Fleming TP
You S

on PubMed

Zuo L
Li L
Wang Q
Fleming TP
You S
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Primary research

Mammaglobin as a potential molecular target for breast cancer drug delivery

Lian Zuo¹ , Ly Li² , Qian Wang³ , Timothy P Fleming⁴ and Shaojin You⁵

¹Atlanta Research and Education Foundation, Atlanta VA Medical Center (151), Decatur, GA 30033, USA

²Department of Chemistry, University of Ningxia School of Chemistry and Chemical Engineering, Yingchuan, Ningxia, PR China

³Department of Chemistry and Biochemistry, University of South Carolina School of Art and Science, Columbia, SC 29208, USA

⁴Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA

⁵Atlanta Research and Education Foundation, Atlanta VA Medical Center (151), Decatur, GA 30033, USA

author email corresponding author email

Cancer Cell International 2009, 9:8doi:10.1186/1475-2867-9-8


Published:	23 March 2009

Additional files

Additional file 1:

FITC Labeled Anti-MAM Antibody and Cell Incubation. Surface binding assay of the FITC labeled anti-MAM on breast cancer cells. After incubation of the FITC labeled anti-MAM, clear fluorescent signals (the green spotty and patchy dots) were shown on the surface of MB361 and MB415 cells (A and B), but not on the surface of HAEC cells (C). Images (D-F) were the phase images taken from the same culture slides with objective lens 10×.